Intensified primary health care at the workplace: investigating the impact on human immunodeficiency virus associated morbidity and tuberculosis epidemiology

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN44114250

Enrollment

6440

Registered

2005-10-14

Start date

2001-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human immunodeficiency virus Infections and Infestations Human immunodeficiency virus

Interventions

Cluster-randomised trial of Small and Medium size Enterprises (SMEs) in Zimbabwe. Randomisation unit: each participating business site Number of sites: 22 The randomisation was to provide Voluntary

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Site: 1. Has HIV prevention policy in place 2. Willing to supply access to workforce and to absenteeism data 3. Agreement of Workers Committee Individuals within sites: 1. Based at the study site (not alternative workplace) 2. On a contract of six months or longer

Exclusion criteria

Exclusion criteria: Individual: 1. Declined consent to participate 2. Sub-contracted or casual contract employee

Design outcomes

Primary

Measure	Time frame
1. Proportion of workers accepting VCT 2. Incidence rates of severe morbidity (composite: death, medical retirement, hospitalisation, TB, illness requiring five days or more off work) according to the VCT strategy allocated	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Zimbabwe

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026